Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Total Current Assets
All assets expected to be converted to cash or used up within one year.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Total Current Assets · Q4 FY2024 · quarter ended Mar 2025
Total current assets falls 8.2% from a year ago
Total current assets stood at $3.37M at the end of Q4 FY2024, down 8.2% from a year earlier.
Context
- Total current assets amounted to 62.9% of total assets at the end of Q4 FY2024, down 12.3 pp from a year earlier.
- Total current assets increased in 0 of the last 2 fiscal years.
- FY2024 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether total current assets keeps falling in the next quarterly balance sheet after a -8.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2024
- 3.37M USD
- Year-over-year change
- -8.2%
- 2-year CAGR
- -9.6%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 3.37M | -8.2% |
| FY2023 | 2024-03-31 | 3.67M | -11.0% |
| FY2022 | 2023-03-31 | 4.12M | — |
Total Current Assets vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 total current assets of $3.37M is the lowest of the 10 companies compared; the peer median is $152.84M.
- Its year-over-year change of -8.2% is the 7th highest of 10, against a peer median of -3.2%.
- Total current assets amounts to 62.9% of total assets for MCTA, versus a peer median of 69.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.32B | -20.0% | -8.9% | 87.8% | |
| Mar 2026 | $298.3M | -8.3% | -24.3% | 66.1% | |
| Mar 2026 | $279.23M | -3.2% | +28.8% | 91.9% | |
| Mar 2026 | $228.27M | -14.9% | -0.8% | 86.8% | |
| Mar 2026 | $152.84M | -4.5% | +11.3% | 56.2% | |
| Mar 2026 | $120.27M | +42.6% | +94.9% | 96.3% | |
| Mar 2026 | $116.86M | +9.4% | -4.7% | 69.5% | |
| Feb 2026 | $67.56M | +44.6% | -29.4% | 46.1% | |
| Mar 2026 | $63.42M | +4798.7% | +797.5% | 10.2% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $3.37M | -8.2% | — | 62.9% |
| Peer median (excluding MCTA) | $152.84M | -3.2% | -0.8% | 69.5% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.